In silico tools to aid medicinal chemistry: optimising bromodomain inhibitors

In silico tools to aid medicinal chemistry: optimising bromodomain inhibitors

<p>Development of ligands for bromodomains has expanded our understanding of gene regulation and epigenetic links to disease. These acetylated lysine ‘reader’ domains are found within larger macromolecules that are involved in gene transcription and degradation. This thesis looks to employ...

书目详细资料
主要作者:	Bluck, J
其他作者:	Biggin, P
格式:	Thesis
出版:	2019

相似书籍

Epigenetic mechanisms in silico: understanding demethylation and rational design of bromodomain inhibitors
由: Coelho, W
出版: (2017)

Development of small molecule CREBBP bromodomain ligands using medicinal chemistry-based approaches
由: Moroglu, M
出版: (2020)

Emerging tools to investigate bromodomain functions
由: Kougnassoukou Tchara, P, et al.
出版: (2019)

Developing inhibitors of bromodomain-histone interactions
由: Hewings, D
出版: (2014)

Small-molecule bromodomain inhibitors for cancer therapy
由: Qi, J, et al.
出版: (2010)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
由: Jennings, L, et al.
出版: (2018)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
由: Ciceri, P, et al.
出版: (2014)

Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.
由: Ferguson, F, et al.
出版: (2013)

Chemical probes and inhibitors of bromodomains outside the BET family
由: Moustakim, M, et al.
出版: (2016)

Developing small molecule inhibitors of bromodomain-histone interactions
由: Wilson, B, et al.
出版: (2015)

Development of small molecule inhibitors of the bromodomain-histone interaction
由: Rooney, TPC
出版: (2014)

Discovery of BET bromodomain inhibitors and their role in target validation
由: Mueller, S, et al.
出版: (2014)

Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
由: Monika Krošel, et al.
出版: (2023-04-01)

Bromodomain inhibitors and cancer therapy: From structures to applications
由: Montserrat Pérez-Salvia, et al.
出版: (2017-05-01)

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
由: Wei Meng, et al.
出版: (2018-10-01)

Pyronaridine as a Bromodomain-Containing Protein 4-<i>N</i>-Terminal Bromodomain (BRD4-BD1) Inhibitor: <i>In Silico</i> Database Mining, Molecular Docking, and Molecular Dynamics Simulation
由: Mahmoud A. A. Ibrahim, et al.
出版: (2023-07-01)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
由: Philpott, M, et al.
出版: (2011)

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.
由: Philpott, M, et al.
出版: (2011)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
由: Ciceri, P, et al.
出版: (2014)

Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple)
由: Laurent Batiste, et al.
出版: (2018-02-01)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
由: Popp, T, et al.
出版: (2016)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
由: Rooney, T, et al.
出版: (2012)

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications
由: Kenneth K. W. To, et al.
出版: (2023-03-01)

Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?
由: Ian J. Groves, et al.
出版: (2020-07-01)

Optimisation of Financial Risk with the Aid of Hedging Tools
由: Jaroslav Slepecky
出版: (2002-12-01)

BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
由: Hammitzsch, A, et al.
出版: (2014)

Synthesis and biological investigation of (+)-JD1, an organometallic BET bromodomain inhibitor
由: Hassell-Hart, S, et al.
出版: (2019)

Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors
由: Noah R. Flynn, et al.
出版: (2021-06-01)

BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
由: Sergey Karakashev, et al.
出版: (2017-12-01)

Chemical tools to probe the role of bromodomains in the parasite Trypanosoma cruzi
由: Laurin, CMC
出版: (2019)

Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
由: Alison M. Kurimchak, et al.
出版: (2016-08-01)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
由: Picaud, S, et al.
出版: (2013)

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
由: Picaud, S, et al.
出版: (2013)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
由: Filippakopoulos, P, et al.
出版: (2012)

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
由: Shu, Shaokun, et al.
出版: (2017)

Cracking the histone code: Developing inhibitors of bromodomain-acetyl-lysine interactions
由: Conway, S
出版: (2013)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
由: Filippakopoulos, P, et al.
出版: (2012)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
由: Hay, D, et al.
出版: (2013)

Effect of BET missense mutations on bromodomain function, inhibitor binding and stability
由: Lori, L, et al.
出版: (2016)

Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells
由: Darshan S. Chandrashekar, et al.
出版: (2024-11-01)